Monopar Therapeutics (MNPR) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.85 | +55.0% |
| 2024 | $-4.11 | -35.2% |
| 2023 | $-3.04 | -266.3% |
| 2022 | $-0.83 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.85 | +55.0% |
| 2024 | $-4.11 | -35.2% |
| 2023 | $-3.04 | -266.3% |
| 2022 | $-0.83 | — |